Literature DB >> 19130316

Community-based study of the association of subclinical thyroid dysfunction with blood pressure.

Yu Duan1, Wen Peng, Xiaodong Wang, Wei Tang, Xiaoyun Liu, Shuhang Xu, Xiaodong Mao, Shangyong Feng, Yu Feng, Youwen Qin, Kuanfeng Xu, Cuiping Liu, Chao Liu.   

Abstract

The relationship between subclinical thyroid dysfunction and blood pressure has been controversial and received unsufficient attention. Thus, we performed a cross-sectional study conducted among 6,992 inhabitants from six districts of Jiangsu Province to investigate the association of subclinical thyroid dysfunction with blood pressure in China. The data from 6,583 subjects (4,115 women and 2,468 men) were included and divided into three groups: euthyroidism (n = 5669, 86.11%), subclinical hyperthyroidism (n = 108, 1.65%), and subclinical hypothyroidism (n = 806, 12.24%). In the groups with subclinical hypothyroidism and hyperthyroidism, systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure were not significantly different from those in the groups with euthyroidism after being adjusted for age, sex, BMI, and smoking status (P > 0.05). More extensively, the SBP and DBP in the group of subclinical hypothyroidism with lower level of TSH (TSH 4.51-10.00 mIU/l, SCH(1)) were significantly higher than those of participants with euthyroidism (P < 0.05). Multivariable logistic analysis revealed that subclinical hypothyroidism with lower TSH (TSH 4.51-10.00 mIU/l) was an independent risk factor for increased SBP (OR = 1.28, 95% CI 1.03-1.59, P = 0.028). Similar results could not be found between groups of euthyroid and subclinical hypothyroid with higher level of TSH (TSH > 10 mIU/l, SCH(2)). Further subdivision of the euthyroid group on the basis of a TSH cut-off of 2.5 mIU/l, revealed still no significant difference in blood pressure after adjustment regardless of whether the TSH levels were in the lower reference (TSH 0.40-2.50 mIU/l, n = 4093) or in the upper reference ranges (TSH 2.51-4.50 mIU/l, n = 1576) (P > 0.05). We concluded that subclinical thyroid dysfunction was not associated with blood pressure. Neither subclinical hyperthyroidism nor subclinical hypothyroidism independently predicted increased blood pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130316     DOI: 10.1007/s12020-008-9138-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  18 in total

1.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

Authors:  B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 2.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

3.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Arch Intern Med       Date:  2005-11-28

4.  The association between subclinical hyperthyroidism and blood pressure in a population-based study.

Authors:  Henry Völzke; Dietrich Alte; Marcus Dörr; Henri Wallaschofski; Ulrich John; Stephan B Felix; Rainer Rettig
Journal:  J Hypertens       Date:  2006-10       Impact factor: 4.844

5.  Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.

Authors:  A E Hak; H A Pols; T J Visser; H A Drexhage; A Hofman; J C Witteman
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

6.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.

Authors:  D H Streeten; G H Anderson; T Howland; R Chiang; H Smulyan
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

7.  Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism.

Authors:  M Petretta; D Bonaduce; L Spinelli; M L Vicario; V Nuzzo; F Marciano; P Camuso; V De Sanctis; G Lupoli
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

8.  Subclinical thyroid dysfunction and blood pressure: a community-based study.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

9.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.

Authors:  G W Ching; J A Franklyn; T J Stallard; J Daykin; M C Sheppard; M D Gammage
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

10.  Hypothyroidism as a cause of hypertension.

Authors:  I Saito; K Ito; T Saruta
Journal:  Hypertension       Date:  1983 Jan-Feb       Impact factor: 10.190

View more
  14 in total

1.  High serum thyrotropin levels are associated with current but not with incident hypertension.

Authors:  Till Ittermann; Daniel Tiller; Christa Meisinger; Carsten Agger; Matthias Nauck; Rainer Rettig; Albert Hofman; Torben Jørgensen; Allan Linneberg; Jacqueline C M Witteman; Oscar H Franco; Karin H Greiser; Karl Werdan; Angela Döring; Alexander Kluttig; Bruno H C Stricker; Henry Völzke
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

2.  Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease.

Authors:  Huanhuan Chen; Qian Xi; Hao Zhang; Bin Song; Xiaoyun Liu; Xiaodong Mao; Jie Li; Hongmei Shen; Wei Tang; Jiaming Zhang; Zhiguo Wang; Yu Duan; Chao Liu
Journal:  Endocrine       Date:  2011-08-30       Impact factor: 3.633

3.  Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?

Authors:  Anna Boggio; Fulvio Muzio; Michela Fiscella; Domenico Sommariva; Adriana Branchi
Journal:  Intern Emerg Med       Date:  2011-12-28       Impact factor: 3.397

4.  Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey.

Authors:  Ji Yoon Choi; Da-An Huh; Kyong Whan Moon
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

Review 5.  Cardiovascular Risk in Patients with Subclinical Hypothyroidism.

Authors:  L H Duntas; Luca Chiovato
Journal:  Eur Endocrinol       Date:  2014-08-28

6.  In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

7.  Masked hypertension in newly diagnosed hypothyroidism: a pilot study.

Authors:  E Piantanida; D Gallo; G Veronesi; N Pariani; E Masiello; P Premoli; L Sassi; A Lai; M L Tanda; M Ferrario; L Bartalena
Journal:  J Endocrinol Invest       Date:  2016-05-19       Impact factor: 4.256

8.  Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women.

Authors:  Jee-Young Oh; Yeon-Ah Sung; Hye Jin Lee
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

9.  L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-10-27       Impact factor: 3.633

10.  Effects of thyroid dysfunction on lipid profile.

Authors:  C V Rizos; M S Elisaf; E N Liberopoulos
Journal:  Open Cardiovasc Med J       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.